Profluent
United States, Emeryville, CA
About Profluent
Profluent is an AI-first company pushing the frontier of de novo protein design to author new biology. Grounded in nature with AI as an interpreter, Profluent’s powerful frontier model platform unlocks solutions that transform medicine, agriculture, and beyond. Founded in 2022 and headquartered in Emeryville, CA, Profluent is backed by leading investors including Altimeter Capital, Bezos Expeditions, Spark Capital, Insight Partners, and Air Street Capital.
Latest Funding
Series BAnnounced 2025-11-19
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
2 signals · where the capital is going
Accelerating design of genome editors and gene-editing systems combining AI sequence analysis with lab work
thescenarionist.com
+1 more capital deployment signal · confidence ratings · source articles
Sign up freeHiring Signals
17 open roles · capital meeting headcount
R&D spend backed by 10 engineering hires, product build in motion
Roles across California, Hybrid (2-3 days on-site), On-site
+4 more hiring signals · full department matrix · role-by-role drill-down
Sign up freeTop hiring departments
In the news
Selling to Profluent? You're in the right place.
Knowing they raised is the start. The edge is what's attached to Profluent.
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Ask AI
What is the unique value proposition of Profluent, and who are their main competitors?
Sign up free to ask AI about Profluent
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
Altimeter Capital
Lead investor · Series B
Tech Stack
Google Font API
Google Analytics
jQuery
Key Highlights
AI InsightsOpenCRISPR-1, the company’s open source gene editor, is used by thousands of commercial operations, academic researchers, and some of the world's largest pharma companies.
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to Profluent
Selling to Profluent? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to Profluent.
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.